Laronde D - Search Results

1

Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.

Gutkind JS, Molinolo AA, Wu X, Wang Z, Nachmanson D, Harismendy O, Alexandrov LB, Wuertz BR, Ondrey FG, Laronde D, Rock LD, Rosin M, Coffey C, Butler VD, Bengtson L, Hsu CH, Bauman JE, Hewitt SM, Cohen EE, Chow HS, Lippman SM, Szabo E. Gutkind JS, et al. Among authors: laronde d. JCI Insight. 2021 Sep 8;6(17):e147096. doi: 10.1172/jci.insight.147096. JCI Insight. 2021. PMID: 34255745 Free PMC article. Clinical Trial.

2

Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.

Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP. Zhang L, et al. Among authors: laronde d. Cancer Res. 2005 Sep 1;65(17):8017-21. doi: 10.1158/0008-5472.CAN-04-3153. Cancer Res. 2005. PMID: 16140975

3

Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device.

Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP. Poh CF, et al. Head Neck. 2007 Jan;29(1):71-6. doi: 10.1002/hed.20468. Head Neck. 2007. PMID: 16983693

4

A magic wand for the community dental office? Observations from the British Columbia Oral Cancer Prevention Program.

Laronde DM, Poh CF, Williams PM, Hislop TG, Zhang L, MacAulay C, Rosin MP. Laronde DM, et al. J Can Dent Assoc. 2007 Sep;73(7):607-9. J Can Dent Assoc. 2007. PMID: 17868508 Free article. No abstract available.

5

Voices from the community--experiences from the dental office: initiating oral cancer screening.

Laronde DM, Bottorff JL, Hislop TG, Poh CY, Currie B, Williams PM, Rosin MP. Laronde DM, et al. J Can Dent Assoc. 2008 Apr;74(3):239-41. J Can Dent Assoc. 2008. PMID: 18387264 Free article. No abstract available.

6

Oral cancer: just the facts.

Laronde DM, Hislop TG, Elwood JM, Rosin MP. Laronde DM, et al. J Can Dent Assoc. 2008 Apr;74(3):269-72. J Can Dent Assoc. 2008. PMID: 18387267 Free article.

7

Squamous cell carcinoma and precursor lesions: diagnosis and screening in a technical era.

Poh CF, MacAulay CE, Laronde DM, Williams PM, Zhang L, Rosin MP. Poh CF, et al. Periodontol 2000. 2011 Oct;57(1):73-88. doi: 10.1111/j.1600-0757.2011.00386.x. Periodontol 2000. 2011. PMID: 21781180 Free PMC article. Review. No abstract available.

8

Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.

Zhang L, Poh CF, Williams M, Laronde DM, Berean K, Gardner PJ, Jiang H, Wu L, Lee JJ, Rosin MP. Zhang L, et al. Cancer Prev Res (Phila). 2012 Sep;5(9):1081-9. doi: 10.1158/1940-6207.CAPR-12-0173. Epub 2012 Aug 21. Cancer Prev Res (Phila). 2012. PMID: 22911111 Free PMC article.

9

High throughput image cytometry for detection of suspicious lesions in the oral cavity.

Macaulay C, Poh CF, Guillaud M, Michele Williams P, Laronde DM, Zhang L, Rosin MP. Macaulay C, et al. J Biomed Opt. 2012 Aug;17(8):086004-1. doi: 10.1117/1.JBO.17.8.086004. J Biomed Opt. 2012. PMID: 23224191 Free article. Clinical Trial.

10

Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practices.

Laronde DM, Williams PM, Hislop TG, Poh C, Ng S, Bajdik C, Zhang L, MacAulay C, Rosin MP. Laronde DM, et al. J Oral Pathol Med. 2014 Jan;43(1):7-13. doi: 10.1111/jop.12090. Epub 2013 Jun 10. J Oral Pathol Med. 2014. PMID: 23750637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page